Key Highlights

  • Shares were down 10.64 percent to USD 2.10 in pre-market trading on November 2, 2026.
  • No company announcement explaining the move was identified for late October to November 2, 2026.
  • First half fiscal 2026 Revenue was USD 8.9 million, down 9.7 percent.
  • Gross Margin improved to 26.9 percent from 24.3 percent.
  • Cash was USD 9.1 million and short-term investments USD 21.0 million at March 31, 2026.

What moved Jin Medical in pre-market trading

Jin Medical International (NASDAQ:ZJYL) was down 10.64 percent to USD 2.10 in pre-market trading on November 2, 2026. No press release, regulatory filing or other company announcement dated from late October to November 2, 2026 was identified to explain the decline.

Without a stated catalyst, the move is best read as ordinary small-cap volatility. Thin pre-market Volume can exaggerate price changes, and the stock has seen sharp swings after earlier company news in 2026.

Recent results

According to a company press release dated August 4, 2026, revenue for the six months ended March 31, 2026 was USD 8.9 million, down 9.7 percent from USD 9.9 million a year earlier. The company attributed the decline mainly to ceasing electric scooter sales and lower wheelchair orders from its largest Japanese customer.

The company reported a net loss of USD 0.2 million, or USD 0.01 per share, versus Net Income of USD 0.01 million a year earlier. Gross Profit was about USD 2.4 million, and gross margin rose to 26.9 percent.

Business background

Jin Medical describes itself as a leading provider of rehabilitation medical equipment in China. Founded in 2006 and headquartered in Changzhou, Jiangsu Province, it designs, manufactures and sells wheelchairs and living aids.

It operates two plants, in Changzhou and Taizhou, and is building a new Facility in Chuzhou, Anhui. The company also completed a variable interest entity transaction in July 2026, which expanded its share base according to a company release that month.

Balance sheet and risks

Cash was USD 9.1 million at March 31, 2026, up from USD 7.5 million at September 30, 2025, with short-term investments of USD 21.0 million. Receivables were about USD 5.5 million, of which 36.3 percent had been collected subsequently, and the company expects most of the remainder by March 31, 2027.

Risks include customer concentration in Japan, the end of scooter sales, and the effect of a larger share count on per share results. The company is also exposed to the usual regulatory and currency considerations of operating in China.

What to watch next

The next scheduled item is the full year fiscal 2026 report for the year ending September 30, 2026, though a date has not been confirmed. Investors will look for order trends from the Japanese customer, progress on the Chuzhou facility and integration of the acquired business.

Any filing in the coming days would help clarify today's decline.